HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Wednesday, 28 August 2013

Recents CEAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  37 papers were listed this time. Here's a few in our areas of research interest:

Martin NK, Hickman M, Miners A, et al. Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons. BMJ Open. 2013 Aug 13;3(8). PMID: 23943776.

Villanti AC, Jiang Y, Abrams DB, et al. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions. PLoS One. 2013 Aug 7;8(8):e71379. Print 2013. PubMed PMID: 23940744.

Paggiaro P, Patel S, Nicolini G, et al. Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effective. Respir Med. 2013 Aug 2. [Epub ahead of print] PubMed PMID: 23916740. 

Please note:
Links are to full-text where available (i.e. open access articles) or to PubMed. ScHARR staff only - if you require help accessing any of the articles mentioned in this blog, please contact Kath Williams, Information Specialist at ScHARR.